S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
Log in
ASX:CUV

Clinuvel Pharmaceuticals Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$23.00
MA: A$23.00
A$23.00
52-Week Range N/A
Volume124,193 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield0.10%
BetaN/A

Competitors

Clinuvel Pharmaceuticals (ASX:CUV) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying CUV stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Clinuvel Pharmaceuticals, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Clinuvel Pharmaceuticals (ASX:CUV) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Profitability

This table compares Clinuvel Pharmaceuticals and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
(CHV)N/AN/AN/A

Valuation & Earnings

This table compares Clinuvel Pharmaceuticals and (CHV)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel Pharmaceuticals$38.34 million0.00$22.04 millionA$0.45N/A
(CHV)N/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals has higher revenue and earnings than (CHV).

Analyst Recommendations

This is a breakdown of recent recommendations for Clinuvel Pharmaceuticals and (CHV), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals0000N/A
(CHV)0000N/A

Summary

Clinuvel Pharmaceuticals beats (CHV) on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals (ASX:CUV) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Profitability

This table compares Clinuvel Pharmaceuticals and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
(DDXS)N/AN/AN/A

Valuation & Earnings

This table compares Clinuvel Pharmaceuticals and (DDXS)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel Pharmaceuticals$38.34 million0.00$22.04 millionA$0.45N/A
(DDXS)N/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals has higher revenue and earnings than (DDXS).

Analyst Recommendations

This is a breakdown of recent recommendations for Clinuvel Pharmaceuticals and (DDXS), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals0000N/A
(DDXS)0000N/A

Summary

Clinuvel Pharmaceuticals beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals (ASX:CUV) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Profitability

This table compares Clinuvel Pharmaceuticals and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
(PREV)N/AN/AN/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and (PREV)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel Pharmaceuticals$38.34 million0.00$22.04 millionA$0.45N/A
(PREV)N/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals has higher revenue and earnings than (PREV).

Analyst Ratings

This is a breakdown of recent ratings for Clinuvel Pharmaceuticals and (PREV), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals0000N/A
(PREV)0000N/A

Summary

Clinuvel Pharmaceuticals beats (PREV) on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals (ASX:CUV) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Profitability

This table compares Clinuvel Pharmaceuticals and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
(TNGN)N/AN/AN/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and (TNGN)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel Pharmaceuticals$38.34 million0.00$22.04 millionA$0.45N/A
(TNGN)N/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals has higher revenue and earnings than (TNGN).

Analyst Ratings

This is a breakdown of recent ratings for Clinuvel Pharmaceuticals and (TNGN), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals0000N/A
(TNGN)0000N/A

Summary

Clinuvel Pharmaceuticals beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals (ASX:CUV) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Profitability

This table compares Clinuvel Pharmaceuticals and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and 138267 (COM.TO)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel Pharmaceuticals$38.34 million0.00C$22.04 millionA$0.45N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals has higher revenue and earnings than 138267 (COM.TO).

Dividends

Clinuvel Pharmaceuticals pays an annual dividend of A$0.03 per share. 138267 (COM.TO) pays an annual dividend of C$0.02 per share. Clinuvel Pharmaceuticals pays out 6.7% of its earnings in the form of a dividend.

Analyst Ratings

This is a breakdown of recent ratings for Clinuvel Pharmaceuticals and 138267 (COM.TO), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals0000N/A
138267 (COM.TO)0000N/A

Clinuvel Pharmaceuticals (ASX:CUV) and 17031 (CNSX:MYM) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and 17031's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clinuvel Pharmaceuticals$38.34 million0.00C$22.04 millionA$0.45N/A
17031N/AN/AN/AN/AN/A

Clinuvel Pharmaceuticals has higher revenue and earnings than 17031.

Profitability

This table compares Clinuvel Pharmaceuticals and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Clinuvel PharmaceuticalsN/AN/AN/A
17031N/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings for Clinuvel Pharmaceuticals and 17031, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Clinuvel Pharmaceuticals0000N/A
170310000N/A

Summary

Clinuvel Pharmaceuticals beats 17031 on 1 of the 1 factors compared between the two stocks.


Clinuvel Pharmaceuticals Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3$380.00flat£0.00N/A0.00Gap Up
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$2.84 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$4.23 million0.00High Trading Volume
Gap Up
ADTX
ADiTx Therapeutics
1.0$3.22flat$0.00N/A0.00Decrease in Short Interest
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.27flat$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00Increase in Short Interest
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00$268,259.000.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.03flat$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00News Coverage
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$30.95flat$0.00N/A0.00Increase in Short Interest
AXIM
AXIM Biotechnologies
0.4$0.71flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.88flat$0.00N/A0.00Decrease in Short Interest
BGT
Bio-Gene Technology
0.8N/AN/A$0.00$82,795.000.00High Trading Volume
News Coverage
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.15 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$240,243.000.00High Trading Volume
Gap Up
BTC
BTC Health
0.8N/AN/A$0.00$131,934.000.00High Trading Volume
News Coverage
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.37flat$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.11flat$0.00N/A0.00Increase in Short Interest
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$18.93flat$0.00N/A0.00Gap Down
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00Decrease in Short Interest
Gap Up
CSL Limited (CSL.AX) logo
CSL
CSL Limited (CSL.AX)
0.8N/AN/A$0.00$9.98 billion0.00Dividend Announcement
High Trading Volume
Gap Up
CLXPF
Cybin
1.0$1.26flat$0.00N/A0.00Decrease in Short Interest
News Coverage
CYP
Cynata Therapeutics
0.5N/AN/A$0.00$2.60 million0.00High Trading Volume
News Coverage
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00Gap Down
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.55flat$0.00N/A0.00Increase in Short Interest
EX1
Exopharm
0.6N/AN/A$0.00$2.68 million0.00High Trading Volume
Gap Up
This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.